Institutional investors hold a majority ownership of PDLI through the 92.32% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $3.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HAYS ADVISORY LLC Bought 1.3 Million shares of PDL BioPharma Inc